Funding of the Development Program. (a) First-Time Pre-Clinical Development Activities. Alexion shall bear [*] percent ([*]%), and XOMA shall bear [*] percent ([*]%), of all Development Expenses incurred in conducting each activity set forth in the Initial Development Plan for the first Product to undergo such activity (collectively, the "First-Time Pre-Clinical Development Activities").
Appears in 3 contracts
Samples: Commercialization Agreement (Alexion Pharmaceuticals Inc), Xoma LTD /De/, Xoma LTD /De/
Funding of the Development Program. (a) First-Time Pre-Clinical Development Activities. Alexion shall bear [*] percent ([*]%), and XOMA shall bear [*] percent ([*]%), of all Development Expenses incurred in conducting each activity set forth in the Initial Development Plan for the first Product to undergo such activity (collectively, the "βFirst-Time Pre-Clinical Development Activities"β).
Appears in 2 contracts
Samples: Commercialization Agreement, Commercialization Agreement (Alexion Pharmaceuticals Inc)